/
PODD
$143.34-$3.10 (-2.12%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
2
institutions
Market cap
$10.1B
69M shares
52-week range
$126.40 – $354.88
7% from low
Sector
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Exchange
NASDAQ
CS
Change$-149.57
Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, more than 600,000 insulin-dependent diabetic patients are using it worldwide.
www.insulet.com- Employees
- 5,400
- IPO / List date
- May 15, 2007
- HQ
- ACTON, MA
Held by traders on TradeandTell
No one on the platform currently holds PODD.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 426,003 | $89.4M |
| Bridgewater Associatesas of 2026-03-31 | 35,336 | $7.4M |
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded PODD yet.
